| 2020-12-18 | Nash Huw M. | COO & CBO | Sale+OE | 50,000 | $60.00 | $3,000,000.00 | -100% | → |
| 2020-12-18 | Kaye Edward M. MD | CEO | Sell | 25,000 | $60.00 | $1,500,000.00 | -82.8% | → |
| 2020-12-01 | Nash Huw M. | COO & CBO | Sale+OE | 5,700 | $49.84 | $284,079.62 | -59.5% | → |
| 2020-11-27 | Kaye Edward M. MD | CEO | Sell | 12,152 | $50.00 | $607,600.00 | -32.7% | → |
| 2020-11-25 | Kaye Edward M. MD | CEO | Sell | 12,848 | $50.00 | $642,400.00 | -25.7% | → |
| 2020-11-24 | Harrison Seth Loring | Director, 10% Owner | Buy | 375,000 | $39.00 | $14,625,000.00 | +2.2% | → |
| 2020-11-24 | Apple Tree Partners IV, L.P. | 10% Owner | Buy | 375,000 | $39.00 | $14,625,000.00 | +2.2% | → |
| 2020-11-23 | TZIANABOS ARTHUR | Director | Sale+OE | 20,000 | $46.03 | $920,565.67 | -48.3% | → |
| 2020-11-10 | Nash Huw M. | COO & CBO | Sale+OE | 50,000 | $45.00 | $2,250,000.00 | -100% | → |
| 2020-11-04 | Tulipano Stephen J | CFO | Sale+OE | 70,000 | $39.00 | $2,729,938.53 | -63.1% | → |
| 2020-11-02 | Nash Huw M. | COO & CBO | Sale+OE | 5,700 | $37.21 | $212,109.89 | -69.2% | → |
| 2020-10-19 | Liau Gene | EVP Research & Preclinical Dev | Sale+OE | 37,851 | $38.16 | $1,444,205.77 | -44.2% | → |
| 2020-10-13 | Liau Gene | EVP Research & Preclinical Dev | Sale+OE | 1,649 | $40.00 | $65,960.00 | -10.9% | → |
| 2020-10-01 | Nash Huw M. | COO & CBO | Sale+OE | 5,700 | $34.54 | $196,900.52 | -71.3% | → |
| 2020-09-09 | Nash Huw M. | COO & CBO | Sale+OE | 47,919 | $30.00 | $1,437,570.00 | -100% | → |
| 2020-09-01 | Nash Huw M. | COO & CBO | Sale+OE | 5,700 | $27.74 | $158,112.63 | -89.1% | → |
| 2020-08-28 | Nash Huw M. | COO & CBO | Sale+OE | 2,081 | $30.00 | $62,430.00 | -100% | → |
| 2020-08-03 | Nash Huw M. | COO & CBO | Sale+OE | 5,700 | $24.73 | $140,943.33 | -100% | → |
| 2020-07-16 | Nash Huw M. | COO & CBO | Sale+OE | 1,900 | $25.06 | $47,614.00 | -100% | → |
| 2020-07-07 | Walker Robin A. | Chief Legal Officer, CCO & Sec | Sell | 941 | $22.50 | $21,172.50 | -100% | → |
| 2020-07-07 | Nash Huw M. | COO & CBO | Sell | 913 | $22.41 | $20,456.86 | -100% | → |
| 2020-07-01 | Nash Huw M. | COO & CBO | Sale+OE | 3,800 | $23.15 | $87,967.72 | -100% | → |
| 2020-06-01 | Ticho Barry | Chief Medical Officer | Sale+OE | 1,365 | $27.39 | $37,386.70 | -0.4% | → |
| 2020-06-01 | Liau Gene | EVP Research & Preclinical Dev | Sale+OE | 20,000 | $26.35 | $527,036.83 | -28.2% | → |
| 2020-06-01 | Nash Huw M. | COO & CBO | Sale+OE | 2,107 | $27.18 | $57,263.26 | -80.8% | → |
| 2020-05-22 | Liau Gene | EVP Research & Preclinical Dev | Sale+OE | 7,500 | $30.00 | $225,000.00 | -35.7% | → |